Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > J Korean Cancer Assoc > Volume 0; > Article
Original Article
WITHDRAWN: Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem Cells
Michael D. Masterman-Smith1,2,3orcid , Nicholas A. Graham4,5, Eduard H. Panosyan6,7, Jack Mottahedeh8, Eric R. Samuels9, Araceli Nunez10, Tiffany Phillips11, Meeryo Choe6,12, Timothy F. Cloughesy6,12, Jorge A. Lazareff7,13, Linda M. Liau13, William H. Yong14, Thomas G. Graeber15,16, Harley I. Kornblum7,12,16, Ming-Fei Lang17, Yanzhao Li18orcid , Jing Sun1,19orcid

DOI: https://doi.org/10.4143/crt.2024.859
Published online: January 7, 2025
1The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China
2Rapid Acceleration of Diagnostics (RADx) COVID-19 Response Program, U.S. National Institutes of Health/National Institutes of Biomedical Imaging and Bioengineering, Bethesda, MD, USA
3Creative Sciences, Inc., Los Angels, CA, USA
4Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, CA, USA
5Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA
6Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, CA, USA
7Department of Pediatrics, David Geffen School of Medicine, University of California at Los Angeles, CA, USA
8Department of Psychiatry, David Geffen School of Medicine, University of California at Los Angeles, CA, USA
9Abbvie Inc., Irvine, CA, USA
10School of Nursing, University of California at Los Angeles, CA, USA
11Samuel Oschin Comprehensive Cancer Center, Cedars Sinai Medical Center, Los Angeles, CA, USA
12Department of Neurology, David Geffen School of Medicine, University of California at Los Angeles, CA, USA
13Department of Neurosurgery, David Geffen School of Medicine, University of California at Los Angeles, CA, USA
14Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, CA, USA
15Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, CA, USA
16California NanoSystems Institute, University of California at Los Angeles, CA, USA
17College of Medicine, Dalian Key Laboratory of Oligosaccharide Recombination and Recombinant Protein Modification, Dalian University, Dalian, China
18Department of Neurosurgery, Affiliated Zhongshan Hospital of Dalian University, Dalian, China
19College of Environmental and Chemical Engineering, Dalian University, Dalian, China
Corresponding author:  Michael D. Masterman-Smith
Tel: 1-310-804-5761  
Email: Michael@creativesciencesinc.com
Yanzhao Li
Tel: 86-411-62893000 
Email: changzhiliyanzhao@126.com
Jing Sun
Tel: 86-411-87402284 
Email: sunjing@dlu.edu.cn
Received: 4 September 2024   • Accepted: 6 January 2025
  • 1,368 Views
  • 74 Download
  • 1 Crossref
  • 0 Scopus
  • Cite
    CITE
    export Copy Download
    Close
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    WITHDRAWN: Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem Cells
    Close

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP